⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8522382 | 0.97 | SHBG (0.39) | — | |
| Methylamine SCHEMBL27951566 | 0.95 | EPHX1 (0.32) | — | |
| SCHEMBL937062 | 0.94 | — | — | |
| SCHEMBL882385 | 0.88 | — | — | |
| Phosphoric Acid SCHEMBL15389186 | 0.87 | MMP2 (0.42) | — | |
| Sulfuric Acid SCHEMBL15389382 | 0.87 | EPHX1 (0.34) | — | |
| Bromide SCHEMBL29487599 | 0.86 | — | — | |
| SCHEMBL28773707 | 0.80 | JAK2 (0.32) | — | |
| SCHEMBL2759860 | 0.79 | TSHR (0.32) | — | |
| SCHEMBL18126126 | 0.77 | PIK3CD (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117285699-A | Solid electrolyte prepolymerization liquid, solid electrolyte and electrochemical device | 深圳市贝特瑞新能源技术研究院有限公司 | 2023-12-26 | — | — | CN | claimed |
| US-12622908-B2 | Topical formulation for a JAK inhibitor | INCYTE CORPORATION (US) | 2026-05-12 | — | — | US | disclosed |
| US-12564593-B2 | Topical formulation for a JAK inhibitor | INCYTE CORPORATION (US) | 2026-03-03 | — | — | US | disclosed |
| US-12544381-B2 | Topical formulation for JAK inhibitor | INCYTE CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250345337-A1 | TOPICAL FORMULATION FOR A JAK INHIBITOR | INCYTE CORP (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250283174-A1 | METHODS FOR ASSESSING THE EXHAUSTION OF HEMATOPOIETIC STEM CELLS INDUCED BY CHRONIC INFLAMMATION | UNIVERSITÉ PARIS CITÉ (FR) | 2025-09-11 | — | — | US | disclosed |
| US-20250255872-A1 | TOPICAL FORMULATION FOR JAK INHIBITOR | INCYTE CORPORATION | 2025-08-14 | — | — | US | disclosed |
| CN-120142527-A | Detection method of lactetinib phosphate positional isomer | 重庆药友制药有限责任公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119977970-A | Luxolitic preparation method of nylon | 雅本(绍兴)药业有限公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-4526469-A1 | METHODS FOR ASSESSING THE EXHAUSTION OF HEMATOPOIETIC STEMS CELLS INDUCED BY CHRONIC INFLAMMATION | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-03-26 | — | — | EP | disclosed |
| EP-2486041-A1 | HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE | Incyte Corporation (US) | 2012-08-15 | — | — | EP | disclosed |
| EP-2470534-A1 | JAK INHIBITION BLOCKS RNA INTERFERENCE ASSOCIATED TOXICITIES | Merck Sharp & Dohme Corp. (US) | 2012-07-04 | — | — | EP | disclosed |
| US-20120157500-A1 | JAK INHIBITION BLOCKS RNA INTERFERENCE ASSOCIATED TOXICITIES | MERCK SHARP & DOHME CORP. | 2012-06-21 | — | — | US | disclosed |
| US-20110288107-A1 | TOPICAL FORMULATION FOR A JAK INHIBITOR | INCYTE CORPORATION | 2011-11-24 | — | — | US | disclosed |
| US-20110086810-A1 | HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d] PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE | INCYTE CORPORATION (US) | 2011-04-14 | — | — | US | disclosed |
| WO-2011044481-A1 | HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE | INCYTE CORPORATION (US) | 2011-04-14 | — | — | WO | disclosed |
| WO-2011025685-A1 | JAK INHIBITION BLOCKS RNA INTERFERENCE ASSOCIATED TOXICITIES | MERCK SHARP & DOHME CORP. (US) | 2011-03-03 | — | — | WO | disclosed |
| EP-2220068-A1 | 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS | Incyte Corporation (US) | 2010-08-25 | — | — | EP | disclosed |
| WO-2010039939-A1 | JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES | INCYTE CORPORATION (US) | 2010-04-08 | — | — | WO | disclosed |
| WO-2009064835-A1 | 4-PYRAZOLYL-N-ARYLPYRIMIDIN-2-AMINES AND 4-PYRAZOLYL-N-HETEROARYLPYRIMIDIN-2-AMINES AS JANUS KINASE INHIBITORS | INCYTE CORPORATION (US) | 2009-05-22 | — | — | WO | disclosed |